Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV reduced its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 7.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,897 shares of the company’s stock after selling 330 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Azenta were worth $205,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in AZTA. Dimensional Fund Advisors LP grew its holdings in shares of Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after buying an additional 421,719 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Azenta by 17.5% in the second quarter. Oppenheimer Asset Management Inc. now owns 18,544 shares of the company’s stock valued at $976,000 after purchasing an additional 2,758 shares during the last quarter. Federated Hermes Inc. increased its holdings in Azenta by 6.3% during the 2nd quarter. Federated Hermes Inc. now owns 432,506 shares of the company’s stock worth $22,758,000 after purchasing an additional 25,586 shares during the last quarter. American Century Companies Inc. raised its position in shares of Azenta by 66.3% in the 2nd quarter. American Century Companies Inc. now owns 69,955 shares of the company’s stock valued at $3,681,000 after purchasing an additional 27,882 shares in the last quarter. Finally, Headlands Technologies LLC grew its position in shares of Azenta by 101.3% during the second quarter. Headlands Technologies LLC now owns 8,611 shares of the company’s stock worth $453,000 after buying an additional 4,333 shares in the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on AZTA shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $69.00 price objective on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI reduced their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $66.40.

Azenta Stock Performance

AZTA stock opened at $47.50 on Wednesday. The stock has a market cap of $2.56 billion, a P/E ratio of -17.53 and a beta of 1.47. Azenta, Inc. has a 52 week low of $44.00 and a 52 week high of $69.16. The firm has a 50 day simple moving average of $51.37 and a 200 day simple moving average of $53.11.

Azenta (NASDAQ:AZTA) last announced its earnings results on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.07 by $0.09. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The firm had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.14 million. During the same quarter last year, the firm posted $0.13 EPS. The business’s quarterly revenue was up 4.2% on a year-over-year basis. Sell-side analysts predict that Azenta, Inc. will post 0.33 EPS for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.